Amgen and Kyowa Kirin to Jointly Develop Potential First-In-Class Treatment for Atopic Dermatitis
Amgen and Kyowa Kirin Co., Ltd. announced an agreement to jointly develop and commercialize KHK4083
Read more
Tag: Amgen
New Tezepelumab Data shows positive results in Asthma Patients
NAVIGATOR Data Published in New England Journal of Medicine, and Latest Data from Tezepelumab Clinical Program ...
Read more
OTEZLA® (apremilast) of AMGEN Significantly improves Mild-To-Moderate Plaque Psoriasis
Clinically Meaningful Improvements in Physician-Reported Outcomes Maintained Through Week 32 Consistent Efficacy Was Observed at Week ...
Read more
Amgen’s Investigational Targeted Treatment Bemarituzumab Granted Breakthrough Therapy Designation
Amgen announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for investigational ...
Read more
Amgen to Acquire Rodeo Therapeutics Corporation
Amgen Inc. and Rodeo Therapeutics Corporation today announced an agreement under which Amgen will acquire Rodeo, ...
Read more